{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:30:02Z","timestamp":1775093402613,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the science and technology project of Zhejiang province","award":["2016c33217"],"award-info":[{"award-number":["2016c33217"]}]},{"name":"the public applied technology research project of Huzhou city","award":["2016GYB02"],"award-info":[{"award-number":["2016GYB02"]}]},{"name":"the public applied technology research project of Huzhou city","award":["2017GYB15"],"award-info":[{"award-number":["2017GYB15"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Familial hypocalciuric hypercalcemia (FHH) is a group of autosomal dominant genetic diseases with persistent hypercalcemia and hypocalciuria. The calcium-sensitive receptor (CaSR) plays an important role in calcium and phosphorus metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 32-year-old man who had diabetes was admitted to our hospital due to poor glycemic control, and was found to have hypercalcemia, hypophosphatemia, and hyperparathyroidism. Single-Photon Emission Computed Tomography (SPECT) (99-mTcMIBI) examination result was negative. The result of 24-h urine calcium was 2.18\u200ammol\/24\u200ah, and the 24-h urinary calcium to creatinine ratio (UCCR) was 0.006. Family survey showed that all of the family members had hypercalcemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The <jats:italic toggle=\"yes\">CaSR<\/jats:italic> gene mutation study revealed that the proband had a homozygous mutation for a T&gt;C nucleotide substitution at c.1664 in exon 6, while both the mother and the father had heterozygous mutations at the same site of exon 6. The clinical diagnosis was considered to be FHH type1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with conventional calcium-lowering therapy which was not effective. Cinacalcet was suggested but not used. The patient received salmon calcitonin nasal spray and furosemide tablets treatment for 1 month after discharge, and then stopped the medication.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>On follow up 4 months after being discharged, the serum calcium level was 3.18\u200ammol\/L, and the PTH level was 275.4\u200ang\/mL. He had felt fatigued, intermittent abdominal pain and lost 3.9\u200akg of weight.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case studied a family with FHH, and the <jats:italic toggle=\"yes\">CaSR<\/jats:italic> gene c.1664T&gt;c mutation was the possible pathogenic cause. If parathyroid location examination is unclear for hyperparathyroidism, the possibility of FHH should be considered. For FHH patients, conventional calcium reduction therapy was ineffective and parathyroid surgery cannot alleviate their hypercalcemia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021940","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:02:21Z","timestamp":1598461341000},"page":"e21940","source":"Crossref","is-referenced-by-count":7,"title":["Familial hypocalciuric hypercalcemia caused by homozygous CaSR gene mutation"],"prefix":"10.1097","volume":"99","author":[{"given":"Feifei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/er.2009-0043","article-title":"The calcium-sensing receptor: a molecular perspective[J]","volume":"32","author":"Magno","year":"2011","journal-title":"Endocr Rev"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrendo.2015.30","article-title":"The calcium-sensing receptor in bone-mechanistic and therapeutic insights","volume":"11","author":"Goltzman","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 [J]","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia[J]","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects [J]","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00223-014-9877-0","article-title":"Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study [J]","volume":"95","author":"Jakobsen","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop[J]","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca (2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism[J]","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2013-3593","article-title":"A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets[J]","volume":"99","author":"Szczawinska","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1687-9856-2012-13","article-title":"A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia[J]","volume":"2012","author":"Tonyushkina","year":"2012","journal-title":"Int J Prdiatr Endocrinol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","article-title":"Hereditary hyperparathyroidism-a consensus report of the European Society oh Endocrine Surgeons (ESES) [J]","volume":"400","author":"Iacobone","year":"2015","journal-title":"Langenbecks Arch Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:57:03Z","timestamp":1694825823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021940"}},"subtitle":["A case report of a family"],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":13,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021940","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}